Amgen ٢٠ أبريل ٢٠٢٦ Zurcher Kantonalbank Zurich Cantonalbank Buys 55,333 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen ١٦ أبريل ٢٠٢٦ Federal Circuit Distinguishes Amgen in Reversal of Invalidation of Teva Headache Treatment Patents - IPWatchdog.com
BioPharma Dive ٦ أبريل ٢٠٢٦ Under-the-skin Tepezza comparable to infused version in key study, Amgen says
Endpoints News ٦ أبريل ٢٠٢٦ Amgen seeks to buoy Tepezza with injectable data in face of incoming competition
FierceBiotech ٤ فبراير ٢٠٢٦ Amgen advances toward lupus redemption while gastric cancer candidate struggles
Endpoints News ٤ فبراير ٢٠٢٦ FDA seeks withdrawal of Amgen's Tavneos, company says it won't pull drug
FierceBiotech ٣٠ يناير ٢٠٢٦ Amgen jilts Kyowa, exiting $400M autoimmune pact after running vast pivotal program
FierceBiotech ١٣ يناير ٢٠٢٦ JPM26, Day 2: Amgen touts MariTide's showing in exploratory weight loss maintenance study
Endpoints News ١٢ ديسمبر ٢٠٢٥ FDA broadens label for Amgen's Uplizna as it enters rare disease competition
FierceBiotech ١١ ديسمبر ٢٠٢٥ Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx